ArticleEndocrine2015

Activity and safety of sunitinib in patients with advanced radioactive iodine-refractory differentiated thyroid carcinoma in clinical practice.

Juan J Díez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.